Lumida
/AXTI
⌘K
AXTI

AXTI

AXTI
$64.77USD↑+0.11%+0.07 today

MARKET CAP

4.2B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$65 – $69

52W RANGE

$3
$143

AI Summary

Stalk
Buy NowMedium

Bearish Exhaustion in early September indicates sellers losing control and raises the probability of a reversal bounce. Price is holding above the rising 9/20 EMAs and 50-SMA with 200-DMA support, reflecting structural repair within the long-term uptrend. Neutral RSI and Options Score suggest limited exhaustion. The Momentum + EPS strategy favors participating on pullbacks into the EMA cluster for continuation.

  • ↑Q2 2026 revenue $47.6M (+164% YoY) driven by AI data-center indium phosphide demand.
  • ↑Non-GAAP net profit $11.9M vs loss of $6.4M in Q2 2025, signaling profitability return.
  • ↓Price-to-sales ratio at 31.5x vs 6.6x industry average, raising overvaluation risk.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

AXT Inc. (NASDAQ: AXTI) is a leading manufacturer of semiconductor substrates, specializing in indium phosphide, gallium arsenide, and germanium. The company has a significant market presence, focusing particularly on the optical communications and data center markets, which are pivotal for the expanding AI infrastructure landscape. Through its vertical integration strategy and long-term supply agreements, AXT aims to capture growth opportunities provided by high-speed connections and AI-driven technological advancements.

Bull says

  • ↑Q2 2026 revenue $47.6M (+164% YoY) driven by AI data-center indium phosphide demand.
  • ↑Non-GAAP net profit $11.9M vs loss of $6.4M in Q2 2025, signaling profitability return.
  • ↑Backlog exceeds $100M, indicating strong order visibility into future quarters.
  • ↑Gross margin widened to 44.9% in Q2 from 8.2%, reflecting pricing power.
  • ↑Doubling indium phosphide capacity in 2026 ahead of schedule to meet demand.
  • ↑Strong momentum and growth factors highlight robust investor interest.

Bear says

  • ↓Price-to-sales ratio at 31.5x vs 6.6x industry average, raising overvaluation risk.
  • ↓Export permit delays for Chinese shipments could stall >50% of revenue.
  • ↓Profitability pressure remains with weak profitability factors and rising input costs.
  • ↓Top five customers account for ~30% of revenue, creating concentration risk.
  • ↓Geopolitical tensions in Asia Pacific add significant near-term headwinds.
  • ↓Elevated leverage risk and weak book-to-price underscore balance-sheet vulnerability.

Investment themes with AXTI

Semiconductors↓ -0.94%

Chips powering modern tech and AI growth

AMD · AMAT · LRCX
Most Shorted Stocks↑ +0.54%

Stocks with highest short interest

LITE · FSLY · SPHR
Animal Spirits 2026↓ -2.81%

ASTS · SERV · UUUU
Lin↓ -2.55%

MU · GLW · VRT

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 08-11-2026neutral

Transcript signals

Bull points

  • we continue to focus strongly on gross margin improvement. In Q3, we expect our margins to improve again and to be in the low mid to mid teens.
  • we continue to focus strongly on gross margin improvement. In Q3, we expect our margins to improve again and to be in the low mid to mid teens.

Bear points

  • we had a non-GAAP net loss of $6.4 million, or 15 cents per share, and paired with a non-GAAP net loss of $8.2 million, or 19 cents per share, in the first quarter of 2025. Non-GAAP net loss in Q2 of 2024 was $0.8 million, or $0.02 per share.
  • Total stock comp was 0.6 million. Net inventory was down by approximately 300K in the second quarter to 80.1 million. This continues to be a focus for us, and we expect to bring it down further in quarters to come.
Read full transcript analysis ›